Clinical Trial Update: Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating low-dose colchicine to address residual vascular risk in patients with peripheral artery disease. The study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis of Extremities
• Peripheral Artery Disease

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Population Health Research Institute | Conditions: Peripheral Arterial Disease, Atherosclerosis of Extremities | Phase 3 | Status: RECRUITING